We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APRE icon
12501
PUT
Aprea Therapeutics
APRE
$8.42M
$9K ﹤0.01%
+600
New +$13.8K
AUUD
12502
Auddia
AUUD
$5.47M
$9K ﹤0.01%
+3
New +$14.3K
EZGO
12503
EZGO Technologies
EZGO
$2.65M
0
QNRX
12504
Quoin Pharmaceuticals
QNRX
$10.2M
$9K ﹤0.01%
+4
New +$15.9K
RDHL
12505
PUT
Redhill Biopharma
RDHL
$3.59M
$9K ﹤0.01%
10
-12
-55% -$16.5K
TOMZ icon
12506
TOMI Environmental Solutions
TOMZ
$13.5M
$9K ﹤0.01%
+4,130
New +$10.1K
TONX
12507
TON Strategy Co
TONX
$148M
$9K ﹤0.01%
+2
New +$8.97K
ABTC
12508
CALL
American Bitcoin Corp
ABTC
$529M
$9K ﹤0.01%
2
SER icon
12509
Serina Therapeutics
SER
$42M
$9K ﹤0.01%
+455
New +$12.3K
QNTM
12510
PUT
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$24.4M
$9K ﹤0.01%
183
-28
-13% -$1.68K
BLNE
12511
CALL
Beeline Holdings
BLNE
$35.8M
$9K ﹤0.01%
+67
New +$11K
CVIIW
12512
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$9K ﹤0.01%
25,337
-599,719
-96% -$259K
MOTS
12513
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$9K ﹤0.01%
102
-2
-2% -$167
AAU
12514
CALL
DELISTED
Almaden Minerals Ltd
AAU
$9K ﹤0.01%
41,200
-5,300
-11% -$1.52K
MARK
12515
PUT
DELISTED
Remark Holdings, Inc.
MARK
$9K ﹤0.01%
1,950
-1,960
-50% -$10.4K
ORTX
12516
CALL
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$9K ﹤0.01%
1,560
+470
+43% +$2.65K
REUN
12517
CALL
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
$9K ﹤0.01%
+2,140
New +$10.7K
NMTR
12518
CALL
DELISTED
9 Meters Biopharma
NMTR
$9K ﹤0.01%
1,795
-6,085
-77% -$57.3K
KRBP
12519
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$9K ﹤0.01%
656
+300
+84% +$4.73K
DNZ.WS
12520
DELISTED
D and Z Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
DNZ.WS
$9K ﹤0.01%
92,051
-139
-0.2% -$24
MONCW
12521
DELISTED
Monument Circle Acquisition Corp. Warrant
MONCW
$9K ﹤0.01%
98,318
-247,646
-72% -$40.4K
MOHO
12522
DELISTED
ECMOHO Limited American Depositary Shares
MOHO
$9K ﹤0.01%
53,084
-351,649
-87% -$69.8K
TYME
12523
CALL
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$9K ﹤0.01%
30,400
-21,900
-42% -$6.31K
ZOM
12524
DELISTED
Zomedica Corp.
ZOM
$9K ﹤0.01%
42,858
-1,788,212
-98% -$455K
AIRI icon
12525
Air Industries Group
AIRI
$12.3M
$8K ﹤0.01%
1,094
-1,916
-64% -$14.1K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.